Table 2.
Age-adjusted average annual LN incidence rates/ 100,000 population (95% CI)* |
Age-adjusted LN Point Prevalence/ 100,000 population (95% CI)* |
||||||||
---|---|---|---|---|---|---|---|---|---|
1976-1989 | 1990-1999 | 2000-2009 | 2010-2018 | 1976-2018 | 01/01/1985 | 01/01/1995 | 01/01/2005 | 01/01/2015 | |
Females | 1.2 (0.4, 2.0) |
1.3 (0.4, 2.2) |
1.7 (0.7, 2.7) |
1.7 (1.0, 2.4) |
1.5 (1.1, 1.9) |
25.9 (11.4, 40.5) |
30.7 (16.7, 44.7) |
36.5 (22.4, 50.7) |
33.4 (24.7, 42.1) |
Males | 0.2 (0.0, 0.6) |
0.0 (0.0, 0.0) |
0.6 (0.0, 1.2) |
0.8 (0.4, 1.3) |
0.5 (0.3, 0.8) |
7.1 (0.0, 15.1) |
6.0 (0.0, 13.0) |
1.4 (0.0, 4.3) |
8.6 (4.1, 13.0) |
Overall | 0.7 (0.2, 1.2) |
0.6 (0.2, 1.1) |
1.2 (0.6, 1.8) |
1.3 (0.9, 1.7) |
1.0 (0.8, 1.3) |
16.8 (8.3, 25.3) |
18.5 (10.7, 26.4) |
19.4 (12.1, 26.8) |
21.2 (16.3, 26.2) |
Rates for females and males were age-adjusted to the 2000 projected US population using eight age categories. Overall rates were age- and sex-adjusted to the 2000 projected US population. Rates are per 100,000 population. Denominator data are based on the Rochester Epidemiology Project census (see reference in the text).